Adaptimmune Therapeutics Cash from Operations (TTM) Insights

Adaptimmune Therapeutics PLC (ADAP)

1.22 +0.03 (+2.52%) USD | NASDAQ | May 03, 10:01

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-140.88M
September 30, 2023	-124.16M
June 30, 2023	-127.16M
March 31, 2023	-124.65M
December 31, 2022	-141.77M
September 30, 2022	-9.883M
June 30, 2022	-6.924M
March 31, 2022	2.868M
December 31, 2021	10.73M
September 30, 2021	-152.42M
June 30, 2021	-123.53M
March 31, 2021	-116.99M
December 31, 2020	-53.59M
September 30, 2020	-36.90M
June 30, 2020	-50.19M
March 31, 2020	-59.45M

Date	Value
December 31, 2019	-112.51M
September 30, 2019	-131.66M
June 30, 2019	-92.12M
March 31, 2019	-93.31M
December 31, 2018	-104.39M
September 30, 2018	-94.06M
June 30, 2018	-90.51M
March 31, 2018	-73.16M
December 31, 2017	-54.32M
September 30, 2017	-30.59M
June 30, 2017	-59.44M
March 31, 2017	-57.93M
December 31, 2016	-48.17M
September 30, 2016	-50.80M
June 30, 2016	-37.49M
March 31, 2016	-34.09M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-152.42M

Minimum

Sep 2021

10.73M

Maximum

Dec 2021

-83.75M

Average

-112.51M

Median

Dec 2019

Cash from Operations (TTM) Benchmarks